| | | Single nucleotide variant (stop lost) | Neuroblastoma, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Haddad syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Haddad syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Haddad syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +1 more | |
| | | Microsatellite (inframe_insertion) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Haddad syndrome +2 more | |
| | | Insertion (inframe_insertion) | Neuroblastoma, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +3 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +2 more | |
| | LOC110011216, PHOX2B (A257V) | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +2 more | |
| | LOC110011216, PHOX2B (A256V) | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 | |
| | LOC110011216, PHOX2B (A249V) | Single nucleotide variant (missense variant) | Haddad syndrome +3 more | |
| | LOC110011216, PHOX2B (A249S) | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | LOC110011216, PHOX2B (A248T) | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +1 more | |
| | LOC110011216, PHOX2B (A244P) | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (nonsense) | Neuroblastoma, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Haddad syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +3 more | |
| | | Deletion (inframe_deletion) | Neuroblastoma, susceptibility to, 2 +2 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +2 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +2 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +2 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Haddad syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Haddad syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Haddad syndrome +3 more | |
| | | Duplication (splice acceptor variant) | Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease +2 more | |
| | | Single nucleotide variant (splice donor variant) | Haddad syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Haddad syndrome +2 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Neuroblastoma, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 2 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |